FDA: Class 1 Recall of Empowered Diagnostics COVID Tests
The FDA issued a Class I recall, the most serious type of recall, for two Empowered Diagnostics COVID-19 Tests.
Read MorePosted by Andy Lundin | Feb 1, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The FDA issued a Class I recall, the most serious type of recall, for two Empowered Diagnostics COVID-19 Tests.
Read MorePosted by Andy Lundin | Jan 31, 2022 | Covid 19, Research |
A new study reported data on a number of hospitalized COVID patients and correlates their serum thyroid hormone levels with biomarkers to critical illness.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The ClearDetect COVID-19 Antigen Home Test (ClearDetect) which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19 |
The severity of COVID-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from pulse oximeters.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The new service features proctored telehealth by which a technician observes proper sample collection, confirms identity, and certifies results reporting.
Read More